16-person safety trial mistakenly framed as world’s answer to glaucoma prevention
Clarity is key, especially when release recommends strategy for reducing cognitive dysfunction
Choir singing for cancer patients? PR news release misses the high notes
Generally strong description of diabetic retinopathy drug trial — but more transparency please
TGen uses slippery language to get around fact that “breakthrough” drug for brain tumors never tested in humans
L-DOPA associated with delayed macular degeneration. There’s a patent for that.
Meditation prevents Alzheimer’s? Claims from a foundation news release get ahead of the evidence